Anti-CD73 antibodies and uses thereof
US12018089B2 · kind B2 · utility
0Cited by
16References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2020 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Nov 25, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-CD73 antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, and pharmaceutical compositions. Methods of treating cancer with the anti-CD73 antibodies are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.